Philips (NYSE: PHG) reported Q3 EPS of EUR0.36. Revenue for the quarter came in at EUR4.3 billion.

Outlook
Philips reiterates its confidence in delivering the full-year 2025 outlook:
• Comparable sales growth: 1%-3%
• Adjusted EBITA margin: 11.3%-11.8%, now expected toward the upper end of the range
• Free cash flow: EUR 0.2-0.4 billion (including the payout in the first quarter of 2025 of EUR 1,025 million Philips Respironics recall-related medical
monitoring and personal injury settlements in the US.)
This outlook excludes ongoing Philips Respironics-related proceedings, including the investigation by the US Department of Justice

For earnings history and earnings-related data on Philips (PHG) click here.